US2008206890A1PendingUtilityA1
Bis(2,9-di-tert-butyl-1,10-phenanthroline)copper(i) complexes, methods of synthesis, and uses therof
Assignee: WISCONSIN ALUMNI RES FOUNDPriority: Jul 31, 2006Filed: Jul 31, 2007Published: Aug 28, 2008
Est. expiryJul 31, 2026(~0 yrs left)· nominal 20-yr term from priority
H10K 85/371G01N 33/52Y02E10/549C07F 1/005C07F 9/5045H01G 9/2031H01G 9/2059Y02P70/50Y02E10/542
41
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides homoleptic and heteroleptic copper(I) complexes having sterically demanding ligands, such as the bis(2,9-di-tert-butyl-1,10-phenanthroline)copper(I) complex and related complexes, methods of synthesis of these complexes and uses thereof. These copper(I) complexes are useful for various applications including photovoltaic cells, light-emitting electrochemical cells, and analyte sensor systems.
Claims
exact text as granted — not AI-modified1 . A copper(I) complex having the formula L 1 L 2 CuX wherein X is a negatively charged ion and the ligands L 1 and L 2 are independently selected from 2,9-di-tert-butyl-1,10-phenanthroline, 2,9-di-tert-butyl-4,7-diphenyl-1,10-phenanthroline, and 2,9-di-2,4,6-trimethylphenyl-1,10-phenanthroline.
2 . The copper(I) complex of claim 1 wherein the ion X is selected from SO 3 CF 3 − , BF 4 − , SbF 6 − , B(C 6 F 5 ) 4 − , PF 6 − and ClO 4 − .
3 . A method of synthesizing a copper(I) complex comprising the steps of:
(a) mixing a ligand L and AgX in a molar ratio of at least 2:1 and solid copper in a polar solvent to result in a (L) 2 CuX complex; and (b) separating the (L) 2 CuX complex from the reaction of step (a), wherein X is a negatively charged ion.
4 . The method of claim 3 wherein the polar solvent is selected from acetone, ethanol and tetrahydrofuran.
5 . The method of claim 3 wherein the ion X is selected from SO 3 CF 3 − , BF 4 − , SbF 6 − , B(C 6 F 5 ) 4 − , PF 6 − and ClO 4 − .
6 . The method of claim 3 wherein the ligand L is selected from: 1,10-phenanthroline; 2,9-di-neo-pentyl-1,10-phenanthroline; 2,9-di-sec-butyl-1,10-phenanthroline; 2,9-di-tert-butyl-1,10-phenanthroline; 2,9-di-tert-butyl-4,7-diphenyl-1,10-phenanthroline; 2,9-dimethyl-1,10-phenanthroline; 2,9-diphenyl-1,10-phenanthroline; 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline; and 2,9-bis-trifluoromethyl-1,10-phenanthroline.
7 . A method of synthesizing a copper(I) complex comprising the steps of:
(a) mixing a ligand L 1 with AgX in a molar ratio of about 1:1 and solid copper in a polar solvent to result in a L 1 CuX complex; (b) isolating the resulting L 1 CuX complex; and (c) adding about one molar equivalent of ligand L 2 to complex L 1 CuX in a non-polar solvent, resulting in a L 1 L 2 CuX complex; and (d) separating the L 1 L 2 CuX complex from the reaction of step (c), wherein X is a negatively charged ion.
8 . The method of claim 7 wherein the ligand L 1 has the same chemical structure as ligand L 2 .
9 . The method of claim 7 wherein the ion X is selected from SO 3 CF 3 − , BF 4 − , SbF 6 − , B(C 6 F 5 ) 4 − , PF 6 − and ClO 4 − .
10 . The method of claim 7 wherein the polar solvent of step (a) is selected from acetone, ethanol and tetrahydrofuran.
11 . The method of claim 7 wherein the non-polar solvent of step (c) is dichloromethane.
12 . The method of claim 7 wherein ligands L 1 and L 2 are independently selected from: 1,10-phenanthroline; 2,9-di-neo-pentyl-1,10-phenanthroline; 2,9-di-sec-butyl-1,10-phenanthroline; 2,9-di-tert-butyl-1,10-phenanthroline; 2,9-di-tert-butyl-4,7-diphenyl-1,10-phenanthroline; 2,9-dimethyl-1,10-phenanthroline; 2,9-diphenyl-1,10-phenanthroline; 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline; and 2,9-bis-trifluoromethyl-1,10-phenanthroline.
13 . A method of detecting a target molecule in a system having or suspected of having the target molecule, the method comprising the steps of:
(a) contacting a luminescent copper(I) L 1 L 2 CuX complex with the system having or suspected of having the target molecule; (b) binding the target molecule to the copper(I) L 1 L 2 CuX complex, wherein the target molecule has a binding constant for Cu(I) that is greater than a Cu(I) binding constant possessed by at least one of the ligands L 1 or L 2 ; and (c) detecting the presence of the target molecule by measuring a reduction or increase in luminescence of the copper(I) complex.
14 . The method of claim 13 wherein the target molecule is selected from CO, CH 3 CN, C 2 H 4 , CH 3 NC, C 2 H 2 , NO and O 2 .
15 . The method of claim 13 wherein the ligands L 1 and L 2 are independently selected from: 1,10-phenanthroline; 2,9-di-neo-pentyl-1,10-phenanthroline; 2,9-di-sec-butyl-1,10-phenanthroline; 2,9-di-tert-butyl-1,10-phenanthroline; 2,9-di-tert-butyl-4,7-diphenyl-1,10-phenanthroline; 2,9-dimethyl-1,10-phenanthroline; 2,9-diphenyl-1,10-phenanthroline; 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline; and 2,9-bis-trifluoromethyl-1,10-phenanthroline.
16 . The method of claim 13 wherein X is a negatively charged ion.
17 . The method of claim 16 wherein the ion X is selected from SO 3 CF 3 − , BF 4 − , SbF 6 − , B(C 6 F 5 ) 4 − , PF 6 − and ClO 4 − .
18 . A dye-sensitized photovoltaic cell comprising a light harvesting unit and a sensitizer, wherein the sensitizer is a copper(I) L 1 L 2 CuX complex, wherein L 1 and L 2 are independently selected from: 1,10-phenanthroline; 2,9-di-neo-pentyl-1,10-phenanthroline; 2,9-di-sec-butyl-1,10-phenanthroline; 2,9-di-tert-butyl-1,10-phenanthroline; 2,9-di-tert-butyl-4,7-diphenyl-1,10-phenanthroline; 2,9-dimethyl-1,10-phenanthroline; 2,9-diphenyl-1,10-phenanthroline; 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline; and 2,9-bis-trifluoromethyl-1,10-phenanthroline; and wherein X is a negatively charged ion.
19 . The photovoltaic cell of claim 18 wherein the ion X is selected from SO 3 CF 3 − , BF 4 − , SbF 6 − , B(C 6 F 5 ) 4 − , PF 6 − and ClO 4 − .
20 . The photovoltaic cell of claim 18 , wherein the light harvesting unit comprises TiO 2 nanoparticles.
21 . A light-emitting electrochemical cell having an emissive layer, the cell comprising a copper(I) L 1 L 2 CuX complex, wherein L 1 and L 2 are independently selected from: 1,10-phenanthroline; 2,9-di-neo-pentyl-1,10-phenanthroline; 2,9-di-sec-butyl-1,10-phenanthroline; 2,9-di-tert-butyl-1,10-phenanthroline; 2,9-di-tert-butyl-4,7-diphenyl-1,10-phenanthroline; 2,9-dimethyl-1,10-phenanthroline; 2,9-diphenyl-1,10-phenanthroline; 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline; and 2,9-bis-trifluoromethyl-1,10-phenanthroline; and wherein X is a negatively charged ion.
22 . The electrochemical cell of claim 21 wherein the ion X is selected from SO 3 CF 3 − , BF 4 − , SbF 6 − , B(C 6 F 5 ) 4 − , PF 6 − and ClO 4 − .
23 . A crystalline form of copper(I) complex having unit cell dimensions of about:
a=11.8246 Å; b=17.8044 Å; and c=27.1111 Å; a=14.906 Å; b=15.188 Å; and c=16.754 Å; a=14.7039 Å; b=25.883(3) Å, and c=16.7036(16) Å; a=14.75449(9) Å, b=15.1383(9) Å, and c=17.9557(11) Å; or a=12.1995(5) Å, b=13.6275(6) Å, and c=14.4027(6) Å.
24 . The crystalline form of copper (I) complex of claim 23 wherein the copper(I) complex is [(2,9-di-tert-butyl-1,10-phenanthroline) 2 Cu][B(C 6 F 5 ) 4 ].Join the waitlist — get patent alerts
Track US2008206890A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.